chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dehydration, Fatigue, Muscle spasms
Clinical narrative: Weakness; Dehydration; Fatigue; Rigors; Nausea; Vomiting; Cramping; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DEHYDRATION (Dehydration), MUSCLE SPASMS (Cramping), FATIGUE (Fatigue) and VOMITING (Vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced MUSCLE SPASMS (Cramping), VOMITING (Vomiting) and NAUSEA (Nausea). On 13-Jan-2021, the patient experienced ASTHENIA (Weakness), DEHYDRATION (Dehydration), FATIGUE (Fatigue) and CHILLS (Rigors). At the time of the report, ASTHENIA (Weakness), DEHYDRATION (Dehydration), MUSCLE SPASMS (Cramping), FATIGUE (Fatigue), VOMITING (Vomiting), CHILLS (Rigors) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on anti-diarrhea and anti-emetic medications.  Concomitant product use was not provided by the reporter
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Weakness; Dehydration; Fatigue; Rigors; Nausea; Vomiting; Cramping; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DEHYDRATION (Dehydration), MUSCLE SPASMS (Cramping), FATIGUE (Fatigue) and VOMITING (Vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced MUSCLE SPASMS (Cramping), VOMITING (Vomiting) and NAUSEA (Nausea). On 13-Jan-2021, the patient experienced ASTHENIA (Weakness), DEHYDRATION (Dehydration), FATIGUE (Fatigue) and CHILLS (Rigors). At the time of the report, ASTHENIA (Weakness), DEHYDRATION (Dehydration), MUSCLE SPASMS (Cramping), FATIGUE (Fatigue), VOMITING (Vomiting), CHILLS (Rigors) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on anti-diarrhea and anti-emetic medications.  Concomitant product use was not provided by the reporter
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Dysgeusia, Weight decreased
Clinical narrative: Disgusted with the salty metallic taste in her mouth; Lost some weight; Feels depressed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Disgusted with the salty metallic taste in her mouth), WEIGHT DECREASED (Lose some weight) and DEPRESSION (Feels depressed) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic lymphocytic leukaemia.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Disgusted with the salty metallic taste in her mouth), WEIGHT DECREASED (Lose some weight) and DEPRESSION (Feels depressed). At the time of the report, DYSGEUSIA (Disgusted with the salty metallic taste in her mouth), WEIGHT DECREASED (Lose some weight) and DEPRESSION (Feels depressed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter. The patient went to her dentist and doctor in regards to her reaction, but they are unsure of what caused it. Her sense of smell is fine and she had some blood work done (results are pending).
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: real strong reaction to first dose; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (real strong reaction to first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (real strong reaction to first dose). At the time of the report, ADVERSE REACTION (real strong reaction to first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment was not reported by the reporter.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Pharyngeal swelling
Clinical narrative: mild throat swelling; worsening symptoms; This spontaneous case was reported by a health care professional and describes the occurrence of PHARYNGEAL SWELLING (mild throat swelling) and CONDITION AGGRAVATED (worsening symptoms) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Penicillin allergy and Allergy (Sulfa allergy.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (mild throat swelling) and CONDITION AGGRAVATED (worsening symptoms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency; EPINEPHRINE (intramuscular) ongoing since an unknown date at a dose of 0.3 mg and METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (mild throat swelling) and CONDITION AGGRAVATED (worsening symptoms) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter.   This case was linked to MOD-2021-028961, MOD-2021-055838, MOD-2021-032365 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Blood pressure measurement, Discomfort, Headache, Heart rate
Clinical narrative: Insomnia; High blood pressure; Headache; a very very bad reaction; a violent debilitating migraine for 13 days; she can barely move her body; couldn't move her arm for 3 days; she was very very ill; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), MALAISE (she was very very ill), DISCOMFORT (she can barely move her body) and LIMB DISCOMFORT (couldn't move her arm for 3 days) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Rheumatoid arthritis, Fibromyalgia, Parkinson's disease and Osteoarthritis. Concomitant products included GABAPENTIN (NEUROTIN [GABAPENTIN]), FLUOXETINE HYDROCHLORIDE (PROZAC), TOPIRAMATE, ZOLPIDEM TARTRATE (AMBIEN), CYCLOBENZAPRINE HYDROCHLORIDE (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]), TRAMADOL HYDROCHLORIDE (ULTRAM ER) and FENTANYL (FENTANYL ABZ) for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (she was very very ill). On 05-Feb-2021, the patient experienced ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), DISCOMFORT (she can barely move her body) and LIMB DISCOMFORT (couldn't move her arm for 3 days). On an unknown date, the patient experienced INSOMNIA (Insomnia), HYPERTENSION (High blood pressure) and HEADACHE (Headache). The patient was treated with SUMATRIPTAN at an unspecified dose and frequency; KETOROLAC TROMETHAMINE (TORADOL) for Migraine, at an unspecified dose and frequency and PROPRANOLOL HYDROCHLORIDE (INDERAL) at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), MALAISE (she was very very ill), DISCOMFORT (she can barely move her body), LIMB DISCOMFORT (couldn't move her arm for 3 days), INSOMNIA (Insomnia), HYPERTENSION (High blood pressure) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 156/128 (Inconclusive) 156/128 and 196/148 (High) 196/148. On an unknown date, Heart rate: 126 (Inconclusive) pulse 126. On an unknown date, Oxygen saturation: 70 (High) 70's and 80 (Low) 80's.         Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: Lab tests, Toradol and Inderal treatment medication, Insomnia, Hypertension and Headache events added.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Insomnia, Limb discomfort, Malaise, Migraine
Clinical narrative: Insomnia; High blood pressure; Headache; a very very bad reaction; a violent debilitating migraine for 13 days; she can barely move her body; couldn't move her arm for 3 days; she was very very ill; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), MALAISE (she was very very ill), DISCOMFORT (she can barely move her body) and LIMB DISCOMFORT (couldn't move her arm for 3 days) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Rheumatoid arthritis, Fibromyalgia, Parkinson's disease and Osteoarthritis. Concomitant products included GABAPENTIN (NEUROTIN [GABAPENTIN]), FLUOXETINE HYDROCHLORIDE (PROZAC), TOPIRAMATE, ZOLPIDEM TARTRATE (AMBIEN), CYCLOBENZAPRINE HYDROCHLORIDE (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]), TRAMADOL HYDROCHLORIDE (ULTRAM ER) and FENTANYL (FENTANYL ABZ) for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (she was very very ill). On 05-Feb-2021, the patient experienced ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), DISCOMFORT (she can barely move her body) and LIMB DISCOMFORT (couldn't move her arm for 3 days). On an unknown date, the patient experienced INSOMNIA (Insomnia), HYPERTENSION (High blood pressure) and HEADACHE (Headache). The patient was treated with SUMATRIPTAN at an unspecified dose and frequency; KETOROLAC TROMETHAMINE (TORADOL) for Migraine, at an unspecified dose and frequency and PROPRANOLOL HYDROCHLORIDE (INDERAL) at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), MALAISE (she was very very ill), DISCOMFORT (she can barely move her body), LIMB DISCOMFORT (couldn't move her arm for 3 days), INSOMNIA (Insomnia), HYPERTENSION (High blood pressure) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 156/128 (Inconclusive) 156/128 and 196/148 (High) 196/148. On an unknown date, Heart rate: 126 (Inconclusive) pulse 126. On an unknown date, Oxygen saturation: 70 (High) 70's and 80 (Low) 80's.         Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: Lab tests, Toradol and Inderal treatment medication, Insomnia, Hypertension and Headache events added.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation
Clinical narrative: Insomnia; High blood pressure; Headache; a very very bad reaction; a violent debilitating migraine for 13 days; she can barely move her body; couldn't move her arm for 3 days; she was very very ill; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), MALAISE (she was very very ill), DISCOMFORT (she can barely move her body) and LIMB DISCOMFORT (couldn't move her arm for 3 days) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Rheumatoid arthritis, Fibromyalgia, Parkinson's disease and Osteoarthritis. Concomitant products included GABAPENTIN (NEUROTIN [GABAPENTIN]), FLUOXETINE HYDROCHLORIDE (PROZAC), TOPIRAMATE, ZOLPIDEM TARTRATE (AMBIEN), CYCLOBENZAPRINE HYDROCHLORIDE (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]), TRAMADOL HYDROCHLORIDE (ULTRAM ER) and FENTANYL (FENTANYL ABZ) for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (she was very very ill). On 05-Feb-2021, the patient experienced ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), DISCOMFORT (she can barely move her body) and LIMB DISCOMFORT (couldn't move her arm for 3 days). On an unknown date, the patient experienced INSOMNIA (Insomnia), HYPERTENSION (High blood pressure) and HEADACHE (Headache). The patient was treated with SUMATRIPTAN at an unspecified dose and frequency; KETOROLAC TROMETHAMINE (TORADOL) for Migraine, at an unspecified dose and frequency and PROPRANOLOL HYDROCHLORIDE (INDERAL) at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (a very very bad reaction), MIGRAINE (a violent debilitating migraine for 13 days), MALAISE (she was very very ill), DISCOMFORT (she can barely move her body), LIMB DISCOMFORT (couldn't move her arm for 3 days), INSOMNIA (Insomnia), HYPERTENSION (High blood pressure) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 156/128 (Inconclusive) 156/128 and 196/148 (High) 196/148. On an unknown date, Heart rate: 126 (Inconclusive) pulse 126. On an unknown date, Oxygen saturation: 70 (High) 70's and 80 (Low) 80's.         Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: Lab tests, Toradol and Inderal treatment medication, Insomnia, Hypertension and Headache events added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Oval warm and raised red patch of two inches wide and one and half inches long on the arm; Oval warm and raised red patch of two inches wide and one and half inches long on the arm; Oval warm and raised red patch of two inches wide and one and half inches long on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Oval warm and raised red patch of two inches wide and one and half inches long on the arm), VACCINATION SITE ERYTHEMA (Oval warm and raised red patch of two inches wide and one and half inches long on the arm) and VACCINATION SITE SWELLING (Oval warm and raised red patch of two inches wide and one and half inches long on the arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Oval warm and raised red patch of two inches wide and one and half inches long on the arm), VACCINATION SITE ERYTHEMA (Oval warm and raised red patch of two inches wide and one and half inches long on the arm) and VACCINATION SITE SWELLING (Oval warm and raised red patch of two inches wide and one and half inches long on the arm). At the time of the report, VACCINATION SITE WARMTH (Oval warm and raised red patch of two inches wide and one and half inches long on the arm), VACCINATION SITE ERYTHEMA (Oval warm and raised red patch of two inches wide and one and half inches long on the arm) and VACCINATION SITE SWELLING (Oval warm and raised red patch of two inches wide and one and half inches long on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dysphonia, Pyrexia, Vision blurred, Visual impairment
Clinical narrative: blurry vision  it's like looking through a straw hole; it's like looking through a straw hole; hoarseness in voice; high fever of 100F; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision  it's like looking through a straw hole), VISUAL IMPAIRMENT (it's like looking through a straw hole), DYSPHONIA (hoarseness in voice) and PYREXIA (high fever of 100F) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Clot blood and Fatigue. Concomitant products included APIXABAN (ELIQUIS), FLUOXETINE HYDROCHLORIDE (PROZAC), FLUOXETINE, PIROXICAM (MAXIDENE), FAMOTIDINE (PEPCID AC), LEVOTHYROXINE and CLONIDINE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VISION BLURRED (blurry vision  it's like looking through a straw hole), VISUAL IMPAIRMENT (it's like looking through a straw hole), DYSPHONIA (hoarseness in voice) and PYREXIA (high fever of 100F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VISION BLURRED (blurry vision  it's like looking through a straw hole), VISUAL IMPAIRMENT (it's like looking through a straw hole), DYSPHONIA (hoarseness in voice) and PYREXIA (high fever of 100F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 100 (High) 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient had a total of 31 symptoms from it at that time. treatment information was not provided
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: fatigue; headache; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (low grade fever) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (low grade fever). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 15-Feb-2021, HEADACHE (headache) had resolved. On 17-Feb-2021, PYREXIA (low grade fever) had resolved. At the time of the report, FATIGUE (fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, Body temperature: 98.3 (normal) 98.3.         No concomitant products were provided by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: NNI-No new information
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash erythematous
Clinical narrative: Red rash, not at the injection site, but down below; Arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash, not at the injection site, but down below) and PERIPHERAL SWELLING (Arm is swollen) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 30L20A and 30L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Red rash, not at the injection site, but down below) and PERIPHERAL SWELLING (Arm is swollen). At the time of the report, RASH ERYTHEMATOUS (Red rash, not at the injection site, but down below) and PERIPHERAL SWELLING (Arm is swollen) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: 90 days since her first dose; COVID-19/got COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19/got COVID) and PRODUCT DOSE OMISSION ISSUE (90 days since her first dose) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced COVID-19 (COVID-19/got COVID). In April 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (90 days since her first dose). The patient was treated with BAMLANIVIMAB at a dose of 1 dosage form. In 2021, COVID-19 (COVID-19/got COVID) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (90 days since her first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Added Treatment information and batch number for suspect drug On 26-Jun-2021: Follow up information received on 26-JUN-2021 contains No New Information On 07-Jul-2021: Follow up document received on 07-JUL-2021 contains No New Information On 26-Jul-2021: NNI; Sender's Comments: Based on the mechanism of action of mRNA-1273 causal association between the event of COVID-19 infection and mRNA-1273 is assessed as not applicable. This report refers to a case of Product Dose Omission for mRNA-1273, with no associated AEs.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: Upper shoulder soreness; chills; Headache; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Upper shoulder soreness), CHILLS (chills) and HEADACHE (Headache) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Upper shoulder soreness), CHILLS (chills) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Upper shoulder soreness), CHILLS (chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Erythema, Headache, Influenza like illness
Clinical narrative: severe migraine; felt fatigued like having the flu; felt dizzy; redness; bruise on the injection site; rash in face; dull headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (dull headache), MIGRAINE (severe migraine), INFLUENZA LIKE ILLNESS (felt fatigued like having the flu), DIZZINESS (felt dizzy) and ERYTHEMA (redness) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced HEADACHE (dull headache), MIGRAINE (severe migraine), INFLUENZA LIKE ILLNESS (felt fatigued like having the flu), DIZZINESS (felt dizzy), ERYTHEMA (redness), RASH (rash in face) and CONTUSION (bruise on the injection site). On 17-Feb-2021, ERYTHEMA (redness) had resolved. At the time of the report, HEADACHE (dull headache), MIGRAINE (severe migraine), INFLUENZA LIKE ILLNESS (felt fatigued like having the flu), DIZZINESS (felt dizzy), RASH (rash in face) and CONTUSION (bruise on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Rash
Clinical narrative: severe migraine; felt fatigued like having the flu; felt dizzy; redness; bruise on the injection site; rash in face; dull headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (dull headache), MIGRAINE (severe migraine), INFLUENZA LIKE ILLNESS (felt fatigued like having the flu), DIZZINESS (felt dizzy) and ERYTHEMA (redness) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced HEADACHE (dull headache), MIGRAINE (severe migraine), INFLUENZA LIKE ILLNESS (felt fatigued like having the flu), DIZZINESS (felt dizzy), ERYTHEMA (redness), RASH (rash in face) and CONTUSION (bruise on the injection site). On 17-Feb-2021, ERYTHEMA (redness) had resolved. At the time of the report, HEADACHE (dull headache), MIGRAINE (severe migraine), INFLUENZA LIKE ILLNESS (felt fatigued like having the flu), DIZZINESS (felt dizzy), RASH (rash in face) and CONTUSION (bruise on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site pruritus, Rash macular, Vaccination site rash
Clinical narrative: Egg sized blotch; Red; Itching; Rash on arm at injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Egg sized blotch), INJECTION SITE PRURITUS (Itching), FATIGUE (Fatigue), VACCINATION SITE RASH (Rash on arm at injection site) and INJECTION SITE ERYTHEMA (Red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced FATIGUE (Fatigue). On 06-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash on arm at injection site). On 07-Feb-2021, the patient experienced INJECTION SITE PRURITUS (Itching). On 09-Feb-2021, the patient experienced RASH MACULAR (Egg sized blotch) and INJECTION SITE ERYTHEMA (Red). At the time of the report, RASH MACULAR (Egg sized blotch), INJECTION SITE PRURITUS (Itching), FATIGUE (Fatigue), VACCINATION SITE RASH (Rash on arm at injection site) and INJECTION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced COVID-19 (tested positive for COVID-19). At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, COVID-19: (Positive) tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Joint stiffness
Clinical narrative: Bitter taste/Metallic taste; tightening of the right side jawof her face; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Bitter taste/Metallic taste) and JOINT STIFFNESS (tightening of the right side jawof her face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced DYSGEUSIA (Bitter taste/Metallic taste) and JOINT STIFFNESS (tightening of the right side jawof her face). At the time of the report, DYSGEUSIA (Bitter taste/Metallic taste) and JOINT STIFFNESS (tightening of the right side jawof her face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pain, Fatigue, Headache, Pain in extremity
Clinical narrative: eyes ache a little bit; a little bit of a headache; pains in his legs; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pains in his legs), FATIGUE (felt tired), HEADACHE (a little bit of a headache) and EYE PAIN (eyes ache a little bit) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported).   On 15-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (pains in his legs) and FATIGUE (felt tired). On 17-Feb-2021, the patient experienced HEADACHE (a little bit of a headache) and EYE PAIN (eyes ache a little bit). On 14-Feb-2021, PAIN IN EXTREMITY (pains in his legs) and FATIGUE (felt tired) was resolving. At the time of the report, HEADACHE (a little bit of a headache) and EYE PAIN (eyes ache a little bit) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: rash reaction in her arm 3*5 inch area in the injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash reaction in her arm 3*5 inch area in the injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced INJECTION SITE RASH (rash reaction in her arm 3*5 inch area in the injection). At the time of the report, INJECTION SITE RASH (rash reaction in her arm 3*5 inch area in the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, Decreased appetite, Fatigue, Headache
Clinical narrative: Rash on my right shoulder/ rash on my right chest/ rash on my right upper back; Arm was sore at the injection site; A headache; Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach); Tired; No appetite; Fever of 101.8°F; Cramps in my left calf; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.8°F), MUSCLE SPASMS (Cramps in my left calf), VACCINATION SITE PAIN (Arm was sore at the injection site), HEADACHE (A headache) and BURNING SENSATION (Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event reported).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (Fever of 101.8°F) and MUSCLE SPASMS (Cramps in my left calf). On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore at the injection site), HEADACHE (A headache), BURNING SENSATION (Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach)), FATIGUE (Tired) and DECREASED APPETITE (No appetite). On 23-Jan-2021, the patient experienced RASH (Rash on my right shoulder/ rash on my right chest/ rash on my right upper back). At the time of the report, PYREXIA (Fever of 101.8°F), MUSCLE SPASMS (Cramps in my left calf), VACCINATION SITE PAIN (Arm was sore at the injection site), HEADACHE (A headache), BURNING SENSATION (Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach)), FATIGUE (Tired), DECREASED APPETITE (No appetite) and RASH (Rash on my right shoulder/ rash on my right chest/ rash on my right upper back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Body temperature: 101.8 f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pyrexia, Rash, Vaccination site pain
Clinical narrative: Rash on my right shoulder/ rash on my right chest/ rash on my right upper back; Arm was sore at the injection site; A headache; Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach); Tired; No appetite; Fever of 101.8°F; Cramps in my left calf; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.8°F), MUSCLE SPASMS (Cramps in my left calf), VACCINATION SITE PAIN (Arm was sore at the injection site), HEADACHE (A headache) and BURNING SENSATION (Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event reported).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (Fever of 101.8°F) and MUSCLE SPASMS (Cramps in my left calf). On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore at the injection site), HEADACHE (A headache), BURNING SENSATION (Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach)), FATIGUE (Tired) and DECREASED APPETITE (No appetite). On 23-Jan-2021, the patient experienced RASH (Rash on my right shoulder/ rash on my right chest/ rash on my right upper back). At the time of the report, PYREXIA (Fever of 101.8°F), MUSCLE SPASMS (Cramps in my left calf), VACCINATION SITE PAIN (Arm was sore at the injection site), HEADACHE (A headache), BURNING SENSATION (Burning sensation in my stomach (squeezing it & shooting flaming arrows out of my stomach)), FATIGUE (Tired), DECREASED APPETITE (No appetite) and RASH (Rash on my right shoulder/ rash on my right chest/ rash on my right upper back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Body temperature: 101.8 f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Injection site mass, Injection site pain, Injection site rash
Clinical narrative: pink reddish patch; 2.5 inch rash and an .75 inch beneath the injection site; changed to becoming really itchy like poison oak - red patch; lump in it - red patch; red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide; it is painful - red patch; felt sick; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (changed to becoming really itchy like poison oak - red patch), ERYTHEMA (pink reddish patch), MALAISE (felt sick), INJECTION SITE MASS (lump in it - red patch) and INJECTION SITE ERYTHEMA (red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lymphadenectomy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PRURITUS (changed to becoming really itchy like poison oak - red patch), INJECTION SITE MASS (lump in it - red patch), INJECTION SITE ERYTHEMA (red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide) and INJECTION SITE PAIN (it is painful - red patch). On an unknown date, the patient experienced ERYTHEMA (pink reddish patch), MALAISE (felt sick) and INJECTION SITE RASH (2.5 inch rash and an .75 inch beneath the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 milligram at bedtime. At the time of the report, PRURITUS (changed to becoming really itchy like poison oak - red patch), ERYTHEMA (pink reddish patch), MALAISE (felt sick), INJECTION SITE MASS (lump in it - red patch), INJECTION SITE ERYTHEMA (red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide), INJECTION SITE PAIN (it is painful - red patch) and INJECTION SITE RASH (2.5 inch rash and an .75 inch beneath the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient used cortisone cream then Benadryl ointment as treatment   This case was linked to MOD-2021-253118 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Significant follow- up appended. On 12-Jul-2021: Follow-up received on 12 Jul 2021 contains No new information. On 28-Jul-2021: Follow up received on 28-jul-2021 contains Non significant follow up
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pruritus
Clinical narrative: pink reddish patch; 2.5 inch rash and an .75 inch beneath the injection site; changed to becoming really itchy like poison oak - red patch; lump in it - red patch; red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide; it is painful - red patch; felt sick; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (changed to becoming really itchy like poison oak - red patch), ERYTHEMA (pink reddish patch), MALAISE (felt sick), INJECTION SITE MASS (lump in it - red patch) and INJECTION SITE ERYTHEMA (red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lymphadenectomy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PRURITUS (changed to becoming really itchy like poison oak - red patch), INJECTION SITE MASS (lump in it - red patch), INJECTION SITE ERYTHEMA (red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide) and INJECTION SITE PAIN (it is painful - red patch). On an unknown date, the patient experienced ERYTHEMA (pink reddish patch), MALAISE (felt sick) and INJECTION SITE RASH (2.5 inch rash and an .75 inch beneath the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 milligram at bedtime. At the time of the report, PRURITUS (changed to becoming really itchy like poison oak - red patch), ERYTHEMA (pink reddish patch), MALAISE (felt sick), INJECTION SITE MASS (lump in it - red patch), INJECTION SITE ERYTHEMA (red patch that is 3/4 inches below the site of injection and is 2 inches long and 1.5 inches wide), INJECTION SITE PAIN (it is painful - red patch) and INJECTION SITE RASH (2.5 inch rash and an .75 inch beneath the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient used cortisone cream then Benadryl ointment as treatment   This case was linked to MOD-2021-253118 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Significant follow- up appended. On 12-Jul-2021: Follow-up received on 12 Jul 2021 contains No new information. On 28-Jul-2021: Follow up received on 28-jul-2021 contains Non significant follow up
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Vaccination site pain
Clinical narrative: Dizzy; Pain in the vaccinated Arm; Tired; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), VACCINATION SITE PAIN (Pain in the vaccinated Arm), FATIGUE (Tired) and NAUSEA (Nausea) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Dizzy), VACCINATION SITE PAIN (Pain in the vaccinated Arm), FATIGUE (Tired) and NAUSEA (Nausea). On 13-Feb-2021, VACCINATION SITE PAIN (Pain in the vaccinated Arm) and NAUSEA (Nausea) had resolved. At the time of the report, DIZZINESS (Dizzy) and FATIGUE (Tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Blood calcium abnormal, Joint range of motion decreased
Clinical narrative: Patient can not lift hand; This spontaneous case was reported by a consumer and describes the occurrence of JOINT RANGE OF MOTION DECREASED (Patient can not lift hand) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT RANGE OF MOTION DECREASED (Patient can not lift hand). At the time of the report, JOINT RANGE OF MOTION DECREASED (Patient can not lift hand) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood calcium abnormal: (abnormal) doctors advised hand problems due to calcium.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.